Molecular mechanisms of necroptosis: an ordered cellular explosion

P Vandenabeele, L Galluzzi… - … reviews Molecular cell …, 2010 - nature.com
For a long time, apoptosis was considered the sole form of programmed cell death during
development, homeostasis and disease, whereas necrosis was regarded as an unregulated …

Nitric oxide and peroxynitrite in health and disease

P Pacher, JS Beckman, L Liaudet - Physiological reviews, 2007 - journals.physiology.org
The discovery that mammalian cells have the ability to synthesize the free radical nitric oxide
(NO) has stimulated an extraordinary impetus for scientific research in all the fields of …

The therapeutic potential of poly (ADP-ribose) polymerase inhibitors

L Virag, C Szabó - Pharmacological reviews, 2002 - ASPET
Poly (ADP-ribose) polymerase-1 (PARP-1) is a member of the PARP enzyme family
consisting of PARP-1 and several recently identified novel poly (ADP-ribosylating) enzymes …

Therapeutic applications of PARP inhibitors: anticancer therapy and beyond

NJ Curtin, C Szabo - Molecular aspects of medicine, 2013 - Elsevier
The aim of this article is to describe the current and potential clinical translation of
pharmacological inhibitors of poly (ADP-ribose) polymerase (PARP) for the therapy of …

Various modes of cell death induced by DNA damage

O Surova, B Zhivotovsky - Oncogene, 2013 - nature.com
The consequences of DNA damage depend on the cell type and the severity of the damage.
Mild DNA damage can be repaired with or without cell-cycle arrest. More severe and …

Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors

P Jagtap, C Szabó - Nature reviews Drug discovery, 2005 - nature.com
Abstract Poly (ADP-ribose) polymerases (PARPs) are involved in the regulation of many
cellular functions. Three consequences of the activation of PARP1, which is the main isoform …

The functional role of poly (ADP-ribose) polymerase 1 as novel coactivator of NF-κB in inflammatory disorders

PO Hassa, MO Hottiger - Cellular and Molecular Life Sciences CMLS, 2002 - Springer
Mammalian poly (ADP-ribose) polymerase 1 (PARP-1) is an abundant nuclear chromatin-
associated protein and belongs to a large family of enzymes that catalyzes the transfer of …

Role of poly (ADP‐ribose) polymerase 1 (PARP‐1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors

P Pacher, C Szabó - Cardiovascular drug reviews, 2007 - Wiley Online Library
Accumulating evidence suggests that the reactive oxygen and nitrogen species are
generated in cardiomyocytes and endothelial cells during myocardial ischemia/reperfusion …

The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley… - Diabetes, 2002 - Am Diabetes Assoc
Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and vascular
complications, which underlie the development of retinopathy, nephropathy, and neuropathy …

The pathophysiology of falciparum malaria

IA Clark, WB Cowden - Pharmacology & therapeutics, 2003 - Elsevier
Falciparum malaria is a complex disease with no simple explanation, affecting organs where
the parasite is rare as well as those organs where it is more common. We continue to argue …